Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 785
Ph III recruiting: 82
Growth YoY: +24.3%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 351–400 of 905 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03675451	PSMA Imaging of Localized Prostate Cancer	completed	Phase 2	20	Weill Medical College of Cornell UniversityOTHER	1	Oct 14, 2020	clinicaltrials
NCT02064582	Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer	completed	Phase 2	7	University of Texas Southwestern Medical CenterOTHER	1	Oct 12, 2020	clinicaltrials